Adverse events after BNT162b2 do not differ for cancer patients
Feb 08, 2022
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
Vaccination, previous infection protect against COVID-19
Jan 24, 2022
During a period of delta predominance, protection was lower among vaccinated persons without a previous COVID-19 diagnosis.
NVX-CoV2373 vaccine protects against COVID-19
Dec 27, 2021
A study conducted in the U.S. and Mexico shows that the vaccine is 90% effective overall and 100% effective against moderate-to-severe disease.
No sign Supreme Court will block COVID-19 vaccination mandates, legal expert say
By
Kathleen Steele Gaivin
Dec 15, 2021
The U.S. Supreme Court declined Monday in a 6-3 ruling to hear a challenge to New York’s vaccine mandate for healthcare workers on religious grounds, and a legal expert says evidence is mounting that...
Abnormal ventilatory patterns common after COVID-19 infection
Dec 09, 2021
Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment and myalgic encephalomyelitis/chronic fatigue.
Rates of COVID-19, severe illness lower with BNT162b2 booster dose
Dec 09, 2021
A second study shows a reduction in the rate of death due to COVID-19 with a booster dose of BNT162b2 (Pfizer–BioNTech).
Most immunosuppressive meds not tied to worse COVID-19 outcomes
Dec 01, 2021
Except for rituximab, no increased risk was seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy.
Decline in infectious conjunctivitis during COVID-19 pandemic
Nov 29, 2021
There was a decrease in emergency department encounters for nonallergic conjunctivitis after the adoption of public health measures to curb COVID-19.
30 percent of hospital-based healthcare personnel unvaccinated
Nov 22, 2021
Vaccination coverage was highest among HCP in children’s hospitals, followed by those in short-term acute care hospitals, long-term acute care hospitals, and critical access hospitals (77, 70.1,...
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.